Opioids
Also in this roundup of health care news: Hospitals step up the war on superbugs; how medical schools try to help doctors understand patients in poverty; and copycat comments, unwitting patients become part of federal rulemaking process.
The Food and Drug Administration Friday approved a new dosage option for buprenorphine and naloxone sublingual film, applied under the tongue as a maintenance treatment for opioid dependence.
The Senate is expected to vote next week on the Opioid Crisis Response Act of 2018, a substitute amendment to the House-passed opioid package (H.R. 6).
The AHA Aug. 28 urged the Drug Enforcement Administration to reconsider its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
AHA comments on the Drug Enforcement Administration’s (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.
The Senate last night voted 85-7 to pass an $857 billion spending package, which includes bills that would fund the departments of Health and Human Services, Defense and Labor for fiscal year 2019.
The Centers for Medicare & Medicaid Services yesterday announced a new payment and service delivery model as part of a multi-pronged strategy to combat the nation’s opioid crisis.
The Food and Drug Administration recently authorized the temporary import of hydromorphone hydrochloride injection from Canada to address a critical shortage of the drug, an opioid pain medication.
The health care community’s efforts alone are not enough to stem the tide of the opioid epidemic. We need more help from the federal government.
Also in this weekly roundup of health care news: Parkland survivor interns at hospital that saved her life; emergency departments seize opportunity to treat opioid withdrawals; black men more likely to get preventive treatments if black doctors tell them to; and health systems form Medicaid…